Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year

1989

Total Raised

$1.1M

About Istac

Provider of immunotherapeutic treatments. The company provides immunotherapeutic treatments based on the use of muramylpeptides as immunomodulators. Muramylpeptides such as Murabutide and Muradimetide could be useful in the treatment of diseases like AIDS, hepatitis C, and cancer.

Istac Headquarter Location

1 rue du Professeur Calmette P.O. Box 245

Lille, 59019,

France

33 1 42 25 27 56

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.